A private company founded in 2000 to develop novel biologics to treat cancer, infectious diseases and autoimmune disorders. The company filed an IPO (NASDAQ: MGNX) on October 2013.
Private diagnostic company developing direct detection analysis using the T2MR magnetic biosensor platform.
Epic Sciences is a diagnostic company developing highly sensitive technology to molecularly characterize circulating tumor cells.
Cleave Therapeutics is a biopharmaceutical company developing novel protein degradation inhibitors for the treatment of cancer.